Edesa Biotech Inc stock is traded at $2.49, with a volume of 83,786,485. It is up +16.36% in the last 24 hours and down -29.06% over the past month. Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Previous Close:
$2.14
Open:
$3.46
24h Volume:
83,786,485
Relative Volume:
9.95
Market Cap:
$24.01M
Revenue:
$328.80K
Net Income/Loss:
-$10.44M
P/E Ratio:
-
EPS:
-$1.34
Net Cash Flow:
-$7.72M
1W Performance:
+2.05%
1M Performance:
-29.06%
6M Performance:
-84.72%
1Y Performance:
+45.61%
1-Day Range:
$2.37$3.93
1-Week Range:
$2.01$3.93
52-Week Range:
$0.72$20.32
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech IncSector
HealthcareIndustry
BiotechnologyPhone
(905) 475-1234Address
100 SPY COURT, MARKHAM, ON, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS